U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07063706) titled 'Pharmaceutical Care for Patients Using Capecitabine' on June 25.
Brief Summary: This is a longitudinal, prospective and intervention study, which will be carried out with patients undergoing treatment with capecitabine, where the impact of pharmaceutical care will be evaluated.
Study Start Date: March 01, 2022
Study Type: INTERVENTIONAL
Condition:
Cancer Colorectal
Cancer Gi
Capecitabine
Pharmaceutical Services
Adverse Drug Reaction (ADR)
Intervention:
OTHER: Intervention Group
Participants in the intervention group received pharmaceutical care
Recruitment Status: COMPLETED
Sponsor: Faculdade de Farmacia
Disclaimer: Curate...